Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

12.1%

4 terminated/withdrawn out of 33 trials

Success Rate

86.2%

-0.4% vs industry average

Late-Stage Pipeline

12%

4 trials in Phase 3/4

Results Transparency

0%

0 of 25 completed trials have results

Key Signals

Enrollment reporting

Analytics

N/A
22(75.9%)
Phase 3
3(10.3%)
Phase 2
2(6.9%)
Phase 2/3
1(3.4%)
Phase 4
1(3.4%)
29Total
N/A(22)
Phase 3(3)
Phase 2(2)
Phase 2/3(1)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (33)

Showing 20 of 33 trials
NCT07592078Completed

EVASTRESS Healthy Subjects

Role: lead

NCT05567692Suspended

Subjects With T2D or at Risk of T2D Cohort Follow-up

Role: lead

NCT06598865Not ApplicableSuspended

Comparative Effectiveness of Prescribed Adapted Physical Activity (APA), Either Practiced Independently After Training, or Supervised by an APA Teacher, on Glycemic Regulation in People With Unbalanced Type 2 Diabetes.

Role: lead

NCT06896045Not ApplicableSuspended

Multicenter Study Evaluating the Relationship Between Perceived Daily Stress Level and Glycemic Level in Subjects With Type 1 Diabetes

Role: lead

NCT06985862Not ApplicableSuspended

Development of Artificial Intelligence Tools for the Detection of Stress Markers and Consideration of Stress States in the Monitoring of Subjects With Type 1 Diabetes

Role: lead

NCT04725591Not ApplicableCompleted

Diabeloop for Teens

Role: lead

NCT06365255Completed

National Epidemiological Study of the Possible Impact of Stress on Glycaemic Control in Patients With Type 1 Diabetes

Role: lead

NCT04537520Not ApplicableCompleted

Interventional Clinical Trial Comparing Kerecis Omega3 Wound Versus SOC in Diabetic Foot Wounds

Role: lead

NCT04257370Not ApplicableCompleted

Kerecis Omega3 Wound Plus SOC vs. SOC Alone in Treating Severe Diabetic Foot Ulcers and Forefoot Amputations

Role: collaborator

NCT01727349Not ApplicableCompleted

Validation of a Predictive Risk Equation for Type 2 Diabetes in Families With Risk

Role: lead

NCT04042207Not ApplicableCompleted

Diabeloop for Highly Unstable Type 1 Diabetes

Role: lead

NCT02521675Not ApplicableCompleted

Validation of Algorithms for Basal Insulin Rate Reductions in Type 1 Diabetic Patients Practising Physical Activity in Real Life Conditions

Role: lead

NCT04190277Not ApplicableTerminated

Safety Assessment of DBLUS System in Adolescent and Adult Patients With Type 1 Diabetes and Assessment of Its Clinical Efficacy (DIABELOOP SP8)

Role: lead

NCT02986256Not ApplicableCompleted

Evaluation of the Management of Diabetic Foot Ulcers by Telemedicine on the Number of Hospital Days in Diabetic Patients

Role: lead

NCT03671915Not ApplicableCompleted

Diabeloop for Kids

Role: lead

NCT02987556Not ApplicableCompleted

Diabeloop WP7 : Crossover Evaluation of the Safety and the Efficacy of Artificial Pancreas Diabeloop (WP7)

Role: lead

NCT02287532Not ApplicableCompleted

Evaluation of the DIABEO System in Poorly Controlled DM1 or DM2 Patients Treated With a Basal-bolus Insulin Regimen

Role: lead

NCT02627911Phase 2Completed

Diabeloop WP6.2 : Crossover Evaluation of Glycemic Control

Role: lead

NCT00934336Not ApplicableCompleted

Importance in Type 1 Diabetes Patients of an Optimized Control of Post-Prandial Glycaemia on Oxidant Stress Prevention

Role: lead

NCT01530789Terminated

Paramedical Consultation in Telemedicine

Role: lead